JP2020503260A5 - - Google Patents

Download PDF

Info

Publication number
JP2020503260A5
JP2020503260A5 JP2019524370A JP2019524370A JP2020503260A5 JP 2020503260 A5 JP2020503260 A5 JP 2020503260A5 JP 2019524370 A JP2019524370 A JP 2019524370A JP 2019524370 A JP2019524370 A JP 2019524370A JP 2020503260 A5 JP2020503260 A5 JP 2020503260A5
Authority
JP
Japan
Prior art keywords
medicament according
amino acid
domain
acid sequence
bispecific antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019524370A
Other languages
English (en)
Japanese (ja)
Other versions
JP7784795B2 (ja
JP2020503260A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/061683 external-priority patent/WO2018093821A1/en
Publication of JP2020503260A publication Critical patent/JP2020503260A/ja
Publication of JP2020503260A5 publication Critical patent/JP2020503260A5/ja
Priority to JP2023174115A priority Critical patent/JP2024012313A/ja
Application granted granted Critical
Publication of JP7784795B2 publication Critical patent/JP7784795B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019524370A 2016-11-15 2017-11-15 抗ｃｄ２０／抗ｃｄ３二重特異性抗体による処置のための投与 Active JP7784795B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023174115A JP2024012313A (ja) 2016-11-15 2023-10-06 抗ｃｄ２０／抗ｃｄ３二重特異性抗体による処置のための投与

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662422391P 2016-11-15 2016-11-15
US62/422,391 2016-11-15
US201762500217P 2017-05-02 2017-05-02
US62/500,217 2017-05-02
PCT/US2017/061683 WO2018093821A1 (en) 2016-11-15 2017-11-15 Dosing for treatment with anti-cd20/anti-cd3 bispecific antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023174115A Division JP2024012313A (ja) 2016-11-15 2023-10-06 抗ｃｄ２０／抗ｃｄ３二重特異性抗体による処置のための投与

Publications (3)

Publication Number Publication Date
JP2020503260A JP2020503260A (ja) 2020-01-30
JP2020503260A5 true JP2020503260A5 (enExample) 2021-01-07
JP7784795B2 JP7784795B2 (ja) 2025-12-12

Family

ID=

Similar Documents

Publication Publication Date Title
JP2025016606A5 (enExample)
JP2018527887A5 (enExample)
JP2017501157A5 (enExample)
JP2025138634A (ja) Ｂ細胞成熟抗原を標的にする多重特異性抗体のための投与計画及び組み合わせ治療
JP2020504723A5 (enExample)
US20230048260A1 (en) Therapeutic anti-cd40 ligand antibodies
JP2009518441A5 (enExample)
JP2019502676A5 (enExample)
CN112154156A (zh) 抗cd38抗体的皮下给药
JP2018519263A5 (enExample)
JP2016503067A5 (enExample)
JP2017507900A5 (enExample)
JP2022512722A (ja) 抗ｃｄ３８抗体の皮下投与を提供する方法
IL263466B2 (en) Anti-CD3 antibodies and methods of using them
HRP20200056T1 (hr) Postupci za liječenje ili sprječavanje migrenske glavobolje
IL297986A (en) Bispecific antibodies against cd3 and cd20
KR20200020902A (ko) 간세포암(hepatocellular carcinoma: HCC)에 대한 면역 치료
JP2020515577A5 (enExample)
CN105407921A (zh) 包含抗cd38抗体和卡非佐米的组合物
TW202104263A (zh) 雙特異性CD123xCD3雙抗體在血液系統惡性腫瘤治療中的給藥方案
US20230203175A1 (en) Anti-CD40 Antibody Combination Treatment for Cancer
JPWO2021224499A5 (enExample)
JPWO2022076462A5 (enExample)
JP2020503260A5 (enExample)
JPWO2022098648A5 (enExample)